BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 26621765)

  • 1. Easing the Burden: Describing the Role of Social, Emotional and Spiritual Support in Research Families with Li-Fraumeni Syndrome.
    Peters JA; Kenen R; Bremer R; Givens S; Savage SA; Mai PL
    J Genet Couns; 2016 Jun; 25(3):529-42. PubMed ID: 26621765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic testing in Li-Fraumeni syndrome: uptake and psychosocial consequences.
    Lammens CR; Aaronson NK; Wagner A; Sijmons RH; Ausems MG; Vriends AH; Ruijs MW; van Os TA; Spruijt L; Gómez García EB; Kluijt I; Nagtegaal T; Verhoef S; Bleiker EM
    J Clin Oncol; 2010 Jun; 28(18):3008-14. PubMed ID: 20479422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pediatric cancer and Li-Fraumeni/Li-Fraumeni-like syndromes: a review for the pediatrician.
    Giacomazzi CR; Giacomazzi J; Netto CB; Santos-Silva P; Selistre SG; Maia AL; Oliveira VZ; Camey SA; Goldim JR; Ashton-Prolla P
    Rev Assoc Med Bras (1992); 2015; 61(3):282-9. PubMed ID: 26248253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Waiting and "weighted down": the challenge of anticipatory loss for individuals and families with Li-Fraumeni Syndrome.
    Werner-Lin A; Young JL; Wilsnack C; Merrill SL; Groner V; Greene MH; Khincha PP
    Fam Cancer; 2020 Jul; 19(3):259-268. PubMed ID: 32222840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TP53 germline mutation testing in 180 families suspected of Li-Fraumeni syndrome: mutation detection rate and relative frequency of cancers in different familial phenotypes.
    Ruijs MW; Verhoef S; Rookus MA; Pruntel R; van der Hout AH; Hogervorst FB; Kluijt I; Sijmons RH; Aalfs CM; Wagner A; Ausems MG; Hoogerbrugge N; van Asperen CJ; Gomez Garcia EB; Meijers-Heijboer H; Ten Kate LP; Menko FH; van 't Veer LJ
    J Med Genet; 2010 Jun; 47(6):421-8. PubMed ID: 20522432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Li-Fraumeni and Li-Fraumeni-like syndrome among children diagnosed with pediatric cancer in Southern Brazil.
    Giacomazzi J; Selistre SG; Rossi C; Alemar B; Santos-Silva P; Pereira FS; Netto CB; Cossio SL; Roth DE; Brunetto AL; Zagonel-Oliveira M; Martel-Planche G; Goldim JR; Hainaut P; Camey SA; Ashton-Prolla P
    Cancer; 2013 Dec; 119(24):4341-9. PubMed ID: 24122735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health professionals' practice for young people with, or at risk of, Li-Fraumeni syndrome: An Australasian survey.
    Forbes Shepherd R; Keogh LA; Werner-Lin A; Delatycki MB; Forrest LE
    J Genet Couns; 2020 Oct; 29(5):737-747. PubMed ID: 31872506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The TP53 gene promoter is not methylated in families suggestive of Li-Fraumeni syndrome with no germline TP53 mutations.
    Finkova A; Vazna A; Hrachovina O; Bendova S; Prochazkova K; Sedlacek Z
    Cancer Genet Cytogenet; 2009 Aug; 193(1):63-6. PubMed ID: 19602465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Systematic Review of How Young People Live with Inherited Disease: What Can We Learn for Li-Fraumeni Syndrome?
    Forbes Shepherd R; Lewis A; Keogh LA; Werner-Lin A; Delatycki MB; Forrest LE
    J Adolesc Young Adult Oncol; 2018 Oct; 7(5):525-545. PubMed ID: 30004834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Li-Fraumeni syndrome].
    Tsunematsu Y
    Nihon Rinsho; 2000 Jul; 58(7):1442-7. PubMed ID: 10921321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Li-Fraumeni syndrome: report of a clinical research workshop and creation of a research consortium.
    Mai PL; Malkin D; Garber JE; Schiffman JD; Weitzel JN; Strong LC; Wyss O; Locke L; Means V; Achatz MI; Hainaut P; Frebourg T; Evans DG; Bleiker E; Patenaude A; Schneider K; Wilfond B; Peters JA; Hwang PM; Ford J; Tabori U; Ognjanovic S; Dennis PA; Wentzensen IM; Greene MH; Fraumeni JF; Savage SA
    Cancer Genet; 2012 Oct; 205(10):479-87. PubMed ID: 22939227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel TP53 germline inframe deletion identified in a Spanish series of Li-fraumeni syndrome suspected families.
    Llovet P; Illana FJ; Martín-Morales L; de la Hoya M; Garre P; Ibañez-Royo MD; Pérez-Segura P; Caldés T; García-Barberán V
    Fam Cancer; 2017 Oct; 16(4):567-575. PubMed ID: 28573494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Li-Fraumeni and related syndromes: correlation between tumor type, family structure, and TP53 genotype.
    Olivier M; Goldgar DE; Sodha N; Ohgaki H; Kleihues P; Hainaut P; Eeles RA
    Cancer Res; 2003 Oct; 63(20):6643-50. PubMed ID: 14583457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Germ-line mutations of TP53 in Li-Fraumeni families: an extended study of 39 families.
    Varley JM; McGown G; Thorncroft M; Santibanez-Koref MF; Kelsey AM; Tricker KJ; Evans DG; Birch JM
    Cancer Res; 1997 Aug; 57(15):3245-52. PubMed ID: 9242456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TP53 and CDKN1A mutation analysis in families with Li-Fraumeni and Li-Fraumeni like syndromes.
    Andrade RC; Dos Santos AC; de Aguirre Neto JC; Nevado J; Lapunzina P; Vargas FR
    Fam Cancer; 2017 Apr; 16(2):243-248. PubMed ID: 27714481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The TP53 mutational spectrum and frequency of CHEK2*1100delC in Li-Fraumeni-like kindreds.
    Siddiqui R; Onel K; Facio F; Nafa K; Diaz LR; Kauff N; Huang H; Robson M; Ellis N; Offit K
    Fam Cancer; 2005; 4(2):177-81. PubMed ID: 15951970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regular surveillance for Li-Fraumeni Syndrome: advice, adherence and perceived benefits.
    Lammens CR; Bleiker EM; Aaronson NK; Wagner A; Sijmons RH; Ausems MG; Vriends AH; Ruijs MW; van Os TA; Spruijt L; Gómez García EB; Cats A; Nagtegaal T; Verhoef S
    Fam Cancer; 2010 Dec; 9(4):647-54. PubMed ID: 20658357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TP53 intron 1 hotspot rearrangements are specific to sporadic osteosarcoma and can cause Li-Fraumeni syndrome.
    Ribi S; Baumhoer D; Lee K; Edison ; Teo AS; Madan B; Zhang K; Kohlmann WK; Yao F; Lee WH; Hoi Q; Cai S; Woo XY; Tan P; Jundt G; Smida J; Nathrath M; Sung WK; Schiffman JD; Virshup DM; Hillmer AM
    Oncotarget; 2015 Apr; 6(10):7727-40. PubMed ID: 25762628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of TP53 Pro72Arg and MDM2 SNP285-SNP309 polymorphisms in an Italian cohort of LFS suggestive patients lacking identifiable TP53 germline mutations.
    Ponti F; Corsini S; Gnoli M; Pedrini E; Mordenti M; Sangiorgi L
    Fam Cancer; 2016 Oct; 15(4):635-43. PubMed ID: 26956143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [New knowledge of Li-Fraumeni syndrome].
    Funato M; Kondo N
    Gan To Kagaku Ryoho; 2013 Feb; 40(2):148-53. PubMed ID: 23411951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.